Dr. Zeeshan Ramzan, MD

Dr. Ramzan practices at Texas Health Fort Worth in Fort Worth, Texas, part of Texas Health Resources.

Dr. Ramzan's NPI, 1689689077, was assigned on July 31, 2006. Dr. Ramzan graduated from King Edward Medical University in 2000. Dr. Ramzan holds Texas license P3231.

Dr. Ramzan's primary practice is Texas Health Fort Worth, at 1301 Pennsylvania Avenue, Fort Worth, TX 76104 in Tarrant County. The practice phone is (817) 250-2100.

Dr. Ramzan's primary practice is Texas Health Fort Worth in Fort Worth, Texas, part of Texas Health Resources. The medical group on file is Texas Health Physicians Group. Dmand AI also links Dr. Ramzan to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ramzan practices, 2 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Ramzan's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Ramzan is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Ramzan's licenses on file in 4 states: Texas, Arizona, Illinois and Pennsylvania.

Dmand AI lists acid reflux, acute gastroduodenitis, colonoscopy, gastroduodenitis, gastroenteritis, irritable bowel syndrome (IBS), pancreas or bile duct endoscopy (ERCP) and upper GI endoscopy among the conditions Dr. Ramzan treats.

CMS data shows 1,208 Medicare services from Dr. Ramzan across 20 procedure codes in 2024, for 421 Medicare patients. Medicare paid $108,160 for them.

CMS counts 421 Medicare patients who saw Dr. Ramzan in 2024. The largest group is 65 to 74, with 176 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 2.26, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ramzan's median patient age at 64, with 56% women.

In 2024, Dr. Ramzan wrote 514 Medicare Part D claims for 266 patients. 81% of them were for generic drugs. CMS names the drug for 422 of them, across 9 drugs with 11 or more claims each, at $63,673 in total drug cost. In 2023, CMS named 325 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Ramzan for performance year 2024, reported individually. Dr. Ramzan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 438 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Ramzan, more than 98% of the clinicians it reports for that procedure.

Dmand AI links 30 papers to Dr. Ramzan, published from 2010 to 2024. 2016 was the busiest year, with 3. The most frequent topics are Gastroparesis, Abdominal Pain and Endosonography. Dr. Ramzan has published most often in Cureus. Dr. Ramzan's most frequent co-authors are Ammar Nassri, MD, Robert Scott Fisher, MD and Sergio Huerta, MD.

CMS Open Payments shows 108 general payments to Dr. Ramzan from 30 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 40% of the total. Boston Scientific Corporation paid the most, $5,811.

Dr. Ramzan graduated from King Edward Medical University in 2000.

Dr. Ramzan is in network with 21 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.